CNBC’s Jim Cramer on Friday guided investors through next week’s most important happenings on Wall Street, saying to watch out for earnings from Walgreens as well as new data about consumer spending. “We’re no longer fighting the Fed, people — they don’t seem inclined to raise rates when they’re supposed to be cutting them, that … Read more
Hormel Foods CEO Jim Snee told CNBC’s Jim Cramer on Thursday that his company is set up to do well as weight-loss drugs gain popularity, citing a varied “protein portfolio.” “No matter how you think about our portfolio, you’re going to encounter protein, which is a really important part of any diet program and especially … Read more
CNBC’s Jim Cramer on Monday said the increasing popularity of GLP-1 drugs — medications used to treat diabetes and obesity — has created some new investing opportunities. According to Cramer, Wall Street feared the effects of these drugs on the market during the fall. Investors soured on companies that made junk food and medical device … Read more